As year-end deals start to sizzle, CSL moves a biotech buyout to the front burner with deal expected Tuesday — report

Rumors have swirled around a potential buyout of Switzerland’s Vifor Pharma by Australia’s CSL since the start of December, and now the gossip reportedly has some truth to it.